Neurology teams play a vital role in caring for patients with multiple myeloma (MM), including those receiving treatment with bispecific antibodies (bsAbs). In this on-demand video, led by an expert neurologist and MM specialist, you will learn to identify risk factors and recognize the signs and symptoms associated with neurological adverse events of bsAb therapy. Tune in to enhance your neurology care approach utilizing multidisciplinary co-management strategies shared by expert faculty to effectively recognize and mitigate these neurology-specific adverse events of bsAbs in MM patients.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/bispecific-antibodies-multiple-myeloma-innovative-multi-modal-accelerator-hub
- Start Date: 2024-08-21 05:00:00
- End Date: 2024-08-21 05:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Janssen (Any division) - Amount: 12500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest